S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
NASDAQ:ARAY

Accuray Stock Forecast, Price & News

$4.36
-0.18 (-3.96 %)
(As of 11/25/2020 04:30 PM ET)
Add
Compare
Today's Range
$4.23
Now: $4.36
$4.63
50-Day Range
$2.65
MA: $3.22
$4.40
52-Week Range
$1.33
Now: $4.36
$4.70
Volume993,977 shs
Average Volume704,049 shs
Market Capitalization$397.95 million
P/E Ratio31.14
Dividend YieldN/A
Beta1.78
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Read More
Accuray logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ARAY
CUSIP00439710
Phone408-716-4600
Employees932

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$382.93 million
Cash Flow$0.02 per share
Book Value$0.74 per share

Profitability

Net Income$3.83 million

Miscellaneous

Market Cap$397.95 million
Next Earnings Date1/26/2021 (Estimated)
OptionableOptionable
$4.36
-0.18 (-3.96 %)
(As of 11/25/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ARAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Accuray (NASDAQ:ARAY) Frequently Asked Questions

How has Accuray's stock price been impacted by COVID-19?

Accuray's stock was trading at $2.27 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ARAY stock has increased by 92.1% and is now trading at $4.36.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Accuray?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Accuray
.

What stocks does MarketBeat like better than Accuray?

Wall Street analysts have given Accuray a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Accuray wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Accuray's next earnings date?

Accuray is scheduled to release its next quarterly earnings announcement on Tuesday, January 26th 2021.
View our earnings forecast for Accuray
.

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) issued its quarterly earnings results on Thursday, August, 13th. The medical equipment provider reported ($0.01) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.02) by $0.01. The medical equipment provider had revenue of $94.98 million for the quarter, compared to analyst estimates of $99.40 million. Accuray had a net margin of 3.41% and a return on equity of 4.33%. During the same quarter in the previous year, the business earned ($0.02) EPS.
View Accuray's earnings history
.

What price target have analysts set for ARAY?

3 brokers have issued twelve-month price targets for Accuray's stock. Their forecasts range from $6.00 to $10.00. On average, they anticipate Accuray's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 83.5% from the stock's current price.
View analysts' price targets for Accuray
.

Are investors shorting Accuray?

Accuray saw a increase in short interest in October. As of October 15th, there was short interest totaling 5,610,000 shares, an increase of 29.0% from the September 30th total of 4,350,000 shares. Based on an average daily volume of 678,200 shares, the short-interest ratio is currently 8.3 days. Approximately 6.4% of the company's shares are sold short.
View Accuray's Short Interest
.

Who are some of Accuray's key competitors?

What other stocks do shareholders of Accuray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accuray investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Intel (INTC), Activision Blizzard (ATVI), Geron (GERN), Sorrento Therapeutics (SRNE), Tesla (TSLA), AbbVie (ABBV), QUALCOMM (QCOM) and ADMA Biologics (ADMA).

Who are Accuray's key executives?

Accuray's management team includes the following people:
  • Mr. Joshua H. Levine, Pres, CEO & Director (Age 62, Pay $739.26k)
  • Mr. Shigeyuki Hamamatsu, Sr. VP & CFO (Age 47, Pay $420.51k)
  • Mr. Patrick R. Spine, Sr. VP & Chief Admin. Officer (Age 49, Pay $395.87k)
  • Mr. Jesse Chew, Sr. VP, Gen. Counsel & Corp. Sec. (Age 39, Pay $396.02k)
  • Ms. Suzanne Winter, Chief Commercial Officer and Sr. VP of R&D (Age 57, Pay $657.6k)
  • Mr. Michael Hoge, Sr. VP of Global Operations
  • Ken Mobeck, VP of Fin. & Investor Relations
  • Beth Kaplan, PR Director
  • Mr. Scott Chapman, Sr. VP of Global Service
  • Shawn Prince, Sr. Director of Patient Access

What is Accuray's stock symbol?

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

Who are Accuray's major shareholders?

Accuray's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.49%), Neuberger Berman Group LLC (6.13%), Archon Capital Management LLC (4.81%), Royce & Associates LP (2.06%), JPMorgan Chase & Co. (2.02%) and State Street Corp (1.96%). Company insiders that own Accuray stock include Andrew J Kirkpatrick, Jesse Chew, Joseph E Whitters, Joshua Levine, Patrick Spine, Shigeyuki Hamamatsu and Suzanne C Winter.
View institutional ownership trends for Accuray
.

Which institutional investors are selling Accuray stock?

ARAY stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Boston Partners, Royce & Associates LP, Neuberger Berman Group LLC, Charles Schwab Investment Management Inc., Archon Capital Management LLC, State Street Corp, and Morgan Stanley. Company insiders that have sold Accuray company stock in the last year include Andrew J Kirkpatrick, Joshua Levine, Shigeyuki Hamamatsu, and Suzanne C Winter.
View insider buying and selling activity for Accuray
.

Which institutional investors are buying Accuray stock?

ARAY stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Acadian Asset Management LLC, BlackRock Inc., Squarepoint Ops LLC, AQR Capital Management LLC, GSA Capital Partners LLP, Arrowstreet Capital Limited Partnership, and Kovack Advisors Inc..
View insider buying and selling activity for Accuray
.

How do I buy shares of Accuray?

Shares of ARAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Accuray's stock price today?

One share of ARAY stock can currently be purchased for approximately $4.36.

How big of a company is Accuray?

Accuray has a market capitalization of $397.95 million and generates $382.93 million in revenue each year. The medical equipment provider earns $3.83 million in net income (profit) each year or ($0.08) on an earnings per share basis. Accuray employs 932 workers across the globe.

What is Accuray's official website?

The official website for Accuray is www.accuray.com.

How can I contact Accuray?

Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. The medical equipment provider can be reached via phone at 408-716-4600 or via email at [email protected]

This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.